Jon E. Angell

Array ( [id] => 15306415 [patent_doc_number] => 10517888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-31 [patent_title] => Treatment and prevention of thrombosis using an anti-miR [patent_app_type] => utility [patent_app_number] => 15/534410 [patent_app_country] => US [patent_app_date] => 2015-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 50 [patent_no_of_words] => 10603 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15534410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11635126 [patent_doc_number] => 09657085 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-05-23 [patent_title] => 'Protease inhibitor: protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria' [patent_app_type] => utility [patent_app_number] => 14/954387 [patent_app_country] => US [patent_app_date] => 2015-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 28 [patent_no_of_words] => 11472 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14954387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10776611 [patent_doc_number] => 20160122768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'AUTOIMMUNE DISEASE TREATMENTS' [patent_app_type] => utility [patent_app_number] => 14/937439 [patent_app_country] => US [patent_app_date] => 2015-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23034 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14937439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13942421 [patent_doc_number] => 10206955 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-19 [patent_title] => Compositions of ascorbic acid and bone morphogenetic protein 4 (BMP-4) for cell growth and uses related thereo [patent_app_type] => utility [patent_app_number] => 14/933052 [patent_app_country] => US [patent_app_date] => 2015-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 9649 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14933052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10822413 [patent_doc_number] => 20160168577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'Clusterin Antisense Therapy for Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 14/932396 [patent_app_country] => US [patent_app_date] => 2015-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6021 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14932396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12098262 [patent_doc_number] => 09855345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-02 [patent_title] => 'Method for producing lipoplex for topical administration and antitumor agent using such lipoplex' [patent_app_type] => utility [patent_app_number] => 15/523222 [patent_app_country] => US [patent_app_date] => 2015-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9673 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10699471 [patent_doc_number] => 20160045618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'Methods And Compositions For Treatment Of Interferon-Resistant Tumors' [patent_app_type] => utility [patent_app_number] => 14/924136 [patent_app_country] => US [patent_app_date] => 2015-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11600 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14924136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10784425 [patent_doc_number] => 20160130581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-12 [patent_title] => 'TARGETING DOMAIN AND RELATED SIGNAL ACTIVATED MOLECULAR DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/882346 [patent_app_country] => US [patent_app_date] => 2015-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 34709 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14882346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14597339 [patent_doc_number] => 10351854 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-16 [patent_title] => Therapeutic inhibition of lactate dehydrogenase and agents therefor [patent_app_type] => utility [patent_app_number] => 15/518009 [patent_app_country] => US [patent_app_date] => 2015-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 124844 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15518009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11350541 [patent_doc_number] => 20160369282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'COMPOSITIONS FOR BACTERIAL MEDIATED GENE SILENCING AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 14/875751 [patent_app_country] => US [patent_app_date] => 2015-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17758 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14875751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11943555 [patent_doc_number] => 20170247706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'CDC25A INHIBITOR FOR THE TREATMENT OF DRUG RESISTANT CANCER OR FOR THE PREVENTION OF TUMOR RELAPSE' [patent_app_type] => utility [patent_app_number] => 15/514043 [patent_app_country] => US [patent_app_date] => 2015-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15090 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15514043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11943610 [patent_doc_number] => 20170247761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'MICRORNA BIOMARKERS FOR POSTTRAUMATIC STRESS DISORDER AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/514175 [patent_app_country] => US [patent_app_date] => 2015-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9772 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15514175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10722695 [patent_doc_number] => 20160068842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => 'miR-29 Mimics and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/848085 [patent_app_country] => US [patent_app_date] => 2015-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17952 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14848085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10476413 [patent_doc_number] => 20150361430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-17 [patent_title] => 'METHODS FOR TREATING EYE DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/837366 [patent_app_country] => US [patent_app_date] => 2015-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 54151 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14837366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10467123 [patent_doc_number] => 20150352138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'Polyvalent RNA-Nanoparticle Compositions' [patent_app_type] => utility [patent_app_number] => 14/836528 [patent_app_country] => US [patent_app_date] => 2015-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15449 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14836528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12172251 [patent_doc_number] => 09890379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-13 [patent_title] => 'Treatment of genetic disorders associated with DNA repeat instability' [patent_app_type] => utility [patent_app_number] => 14/809483 [patent_app_country] => US [patent_app_date] => 2015-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 10011 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14809483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10437423 [patent_doc_number] => 20150322435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-12 [patent_title] => 'FORMULATIONS FOR TREATING AMYLOIDOSIS' [patent_app_type] => utility [patent_app_number] => 14/807223 [patent_app_country] => US [patent_app_date] => 2015-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9785 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14807223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11670332 [patent_doc_number] => 20170159052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF USHER SYNDROME TYPE 2' [patent_app_type] => utility [patent_app_number] => 15/324572 [patent_app_country] => US [patent_app_date] => 2015-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18539 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15324572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12246294 [patent_doc_number] => 09919058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-20 [patent_title] => 'Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer' [patent_app_type] => utility [patent_app_number] => 15/326387 [patent_app_country] => US [patent_app_date] => 2015-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 40 [patent_no_of_words] => 24581 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405334 [patent_doc_number] => 20150290343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'EXOSOME TRANSFER OF NUCLEIC ACIDS TO CELLS' [patent_app_type] => utility [patent_app_number] => 14/750457 [patent_app_country] => US [patent_app_date] => 2015-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4969 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14750457 [rel_patent_id] =>[rel_patent_doc_number] =>)